59086-51-0

Upstream product

• 5443-37-8 ethyl 4-(n-prop-2'-enyloxy)benzoate 
• 120-47-8 Ethyl 4-hydroxybenzoate 

Downstream Products

• 861530-38-3 3-allyl-4-allyloxy-benzoic acid ethyl ester 
• 71318-55-3 4-hydroxy-3-allyl-benzoic acid 
• 7501-09-9 3-allyl-4-methoxy-benzoic acid 
• 857599-53-2 4-methoxy-3-[1-(4-methoxy-phenyl)-propyl]-benzoic acid 
• 20490-22-6 2,4,6-tris(2-propenyl)phenol 
• 100311-34-0 4-Hydroxy-3.5-dipropyl-benzoesaeure-aethylester 
• 252234-10-9 4-carboxy-2-[E-1-propenyl]phenol 
• 100311-33-9 3,5-diallyl-4-hydroxy-benzoic acid 
• 100347-69-1 3,5-diallyl-4-allyloxy-benzoic acid 
• 100347-70-4 3,5-diallyl-4-allyloxy-benzoic acid ethyl ester 
• 5443-37-8 ethyl 4-(n-prop-2'-enyloxy)benzoate 
• 123014-68-6 4-hydroxy-3-propylbenzoic acid ethyl ester 

Relevant academic research and scientific papers

Laterally connected bent-core dimers and bent-core-rod couples with nematic liquid crystalline phases

First examples of laterally connected bent-core dimesogens and liquid crystalline dimesogens involving bent-core units and rod-like units are reported. Four distinct types of dimesogens have been synthesized and investigated by polarizing microscopy (PM),

Benzopyran derivatives having leukotriene-antagonistic action

The present invention relates to novel 4-oxo-4H-1-benzopyran compounds containing benzyloxymethyl, 3-phenylpropyl, or other araliphatic substituents in their 8-position. These compounds show a leukotriene-antagonistic activity. The compounds are characterized by good oral adsorption. The compounds of the present invention may be used as anti-inflammatory and antiallergic medicaments, and in the treatment of cardiovascular diseases.

Quinclidine derivatives as squalene synthase inhibitors

Quinuclidine derivatives of formula, and their pharmaceutically acceptable salts, in which: R1 is hydrogen or hydroxy; R2 is hydrogen; pr R1 and R2 are joined together so that CR1 -CR2 is a